22-08-2022 Grey Zone Lymphoma

In this Deep Dive Session, Dr. Romana Jassat and Dr. Garrick Laudin present a comprehensive overview of Gray Zone Lymphoma, a rare and challenging disease entity that straddles the characteristics of both Hodgkin’s and non-Hodgkin’s lymphomas. They discuss the diagnostic challenges, the latest WHO definitions, and potential treatment strategies, including the use of targeted therapeutic agents such as Brentuximab-Vedotin and Rituximab.

See more from BLOODSA

Scroll to Top